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Preventing ventilator-associated pneumonia—a mixed-method
study to find behavioral leverage for better protocol adherence
Aline Wolfensberger MDa, Marie-Theres Meier RNa, Lauren Clack PhD, Peter W. Schreiber MD and Hugo Sax MD
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, University of Zurich, Zurich, Switzerland
Abstract
Objective: Preventing ventilator-associated pneumonia (VAP) is an important goal for intensive care units (ICUs). We aimed to identify
the optimal behavior leverage to improve VAP prevention protocol adherence.
Design: Mixed-method study using adherence measurements to assess 4 VAP prevention measures and qualitative analysis of
semi-structured focus group interviews with frontline healthcare practitioners (HCPs).
Setting: The 6 ICUs in the 900-bed University Hospital Zurich in Zurich, Switzerland.
Patients and participants: Adherence to VAP prevention measures were assessed in patients with a device for invasive ventilation (ie,
endotracheal tube, tracheostomy tube). Participants in focus group interviews included a convenience samples of ICU nurses and physicians.
Results: Between February 2015 and July 2017, we measured adherence to 4 protocols: bed elevation showed adherence at 27% (95%
confidence intervals [CI], 23%–31%); oral care at 41% (95% CI, 36%–45%); sedation interruption at 81% (95% CI, 74%–85%); and
subglottic suctioning at 88% (95% CI, 83%–92%). Interviews were analyzed first inductively according a grounded theory approach then
deductively against the behavior change wheel (BCW) framework. Main behavioral facilitators belonged to the BCW component ‘reflective
motivation’ (ie, perceived seriousness of VAP and self-efficacy to prevent VAP). The main barriers belonged to ‘physical capability’ (ie, lack
of equipment and staffing and side-effects of prevention measures). Furthermore, 2 primarily technical approaches (ie, ‘restructuring
environment’ and ‘enabling HCP’) emerged as means to overcome these barriers.
Conclusions: Our findings suggest that technical, rather than education-based, solutions should be promoted to improve VAP prevention.
This theory-informed mixed-method approach is an effective means of guiding infection prevention efforts.
(Received 8 May 2018; accepted 22 July 2018)
Intensive care unit (ICU) patients are at high risk for developing
healthcare-associated infections, and ventilator-associated pneu-
monia (VAP) is the most common of these infections.1 VAP is
defined as pneumonia occurring 48 h following endotracheal
intubation with the ventilator being in place the date of event or
the day before.2 The incidence of VAP was reported to be as high
as 42%,3–5 but estimates vary substantially depending on different
diagnostic scoring systems.3,6 Also, VAP is associated with sub-
stantial morbidity, an increase in mortality, and excess costs.7,8
Multiple international guidelines regarding the prevention of
VAP are available.9–13 Most hospitals implement VAP prevention
elements as part of a prevention bundle, but the components of
such bundles may vary from hospital to hospital.14 Unfortunately,
sufficient evidence about the efficacy of single bundle components
in preventing VAP is lacking.14 Some prevention measures,
such as oral care with chlorhexidine, have recently come under
suspicion as being potentially harmful.15,16 Nevertheless, the
potential to decrease VAP rates using VAP prevention bundles
has been demonstrated by many authors,17–22 and the preventable
proportion of VAP was estimated to be 52%–55%.23,24
Effective implementation is as important as choosing the right
bundle components.14 Adherence to and knowledge about VAP
prevention measures were shown to be poor in several studies.19,25,26
Adherence can be raised through different implementation pro-
grams.19,27 A systematic review identified education (eg, training
sessions or development of concise summaries of the evidence) and
execution strategies (eg, standardization of care processes and
building redundancies into routine care) as strategies to enhance the
adoption of VAP prevention measures.28 These authors also men-
tioned multidisciplinary teamwork, involvement of champions, and
networking among peers as engagement strategies.28 Another sys-
tematic review showed that improvement in adherence to preventive
measures occurred once audit and feedback of adherence rates with
or without reminder systems were introduced in addition to orga-
nizational change efforts and education of frontline healthcare
practitioners (HCPs).29 Generally, it is well accepted that theory-
based implementation strategies are more effective in achieving
sustained behavior changes.30
In our hospital, a 9-element VAP bundle was designed in 2011
by an interprofessional working group. Implementation of the
bundle began in 2013. In February 2015, the hospital infection
prevention and control (IPC) team measured adherence to
Cite this article: Wolfensberger A, et al. (2018). Preventing ventilator-associated
pneumonia—a mixed-method study to find behavioral leverage for better protocol
adherence. Infection Control & Hospital Epidemiology. 2018: 1–8. doi: 10.1017/
ice.2018.195
Author for correspondence: Aline Wolfensberger, MD, Division of Infectious Dis-
eases and Hospital Epidemiology, University Hospital Zurich, University of Zurich,
Rämistrasse 100 CH-8091 Zurich, Switzerland. E-mail: aline.wolfensberger@usz.ch
a Authors of equal contribution.
© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved.
selected bundle elements and found suboptimal overall adherence
rates. Therefore, the IPC team chose a mixed-methods approach
to assess adherence to VAP prevention measures and identify
barriers to and facilitators of protocol adherence.
Methods
Setting
The study took place at the University Hospital Zurich (UHZ),
Zurich, Switzerland, a 900-bed tertiary-care teaching hospital
featuring all medical specialties except pediatrics and orthopedics.
In total, the study included 64 beds in 6 ICUS: medical ICU,
general thoracic and transplant surgery ICU, trauma ICU, burn
ICU, cardiac surgery ICU, and neurosurgery ICU.
The University Hospital Zurich (UHZ) VAP bundle
The UHZ VAP bundle was created by an interprofessional group
comprising IPC team members, ICU nurses and physicians, and
anesthesiologists. It included 9 elements: (1) continuous application
of a sedation and weaning protocols with daily sedation interrup-
tions; (2) head of the bed elevation of ≥30°; (3) oral decontami-
nation with chlorhexidine mouth wash twice daily; (4) the use of
endotracheal tubes with continuous subglottic secretion drainage;
(5) hand hygiene according to the WHO Five Moments concept31;
(6) use of noninvasive ventilation (NIV) whenever feasible; (7)
periodic changes of ventilator tubing and filters biweekly; (8) use of
closed suction systems; and (9) daily evaluation of stress ulcer
prophylaxis to limit its use. The bundle was enacted by the medical
director in 2011, and the standard operating procedure (SOP) was
made accessible via the hospital’s intranet. In 2013, the UHZ VAP
bundle was formally implemented under the lead of ICU nurses by
providing education and practical training. In June 2016, an ‘action
month,’ 5 of the 9 bundle elements (ie, head of bed elevation, oral
care with chlorhexidine, hand hygiene, NIV, closed suction system)
were again addressed by providing education, practical training,
contests, and posters and stickers as reminders. The elements were
chosen by the ICU teams based on feedback adherence rates and the
anticipated need for training.
Adherence measurements
Adherence to VAP prevention elements was assessed by overt,
nonparticipatory observations in February 2015 (measurement 1),
in August 2015 (measurement 2), in July 2016 (measurement 3) and
continuously from July to September 2017 (measurement 4).
Investigators visited all ICUs once or twice daily during weekdays
between 8 AM and 6 PM. We evaluated 4 bundle elements whose
execution relied on HCP decision making rather than on standar-
dized workflows. (1) Daily sedation interruption was assessed by
reviewing the handwritten tracking sheet and by oral confirmation
by the responsible nurse. We excluded patients with severe hemo-
dynamic shock, a subset of specified intracranial injuries or neu-
rologic diseases that challenge cerebral perfusion, extracorporeal
membrane oxygenation, neuromuscular blocking agents, and ther-
apeutic hypothermia, as well as those in need of a kinetic bed
system. (2) Head of bed elevation was measured using a Smart-
phone application for angle measurement (Mammut Safety APP,
version 1.0, Mammut Sports Group AG, Seon, Switzerland). We
excluded patients with hemodynamic instability, instable spinal or
pelvic fracture, and specific intracranial injuries or neurologic dis-
eases that impair cerebral perfusion pressure. (3) Twice-daily oral
care with chlorhexidine was assessed by review of the electronic
patient record. (4) Continuous subglottic secretion drainage was
assessed by direct observations. We excluded patients with endo-
tracheal or tracheostomy tubes not featuring a suction port. In
measurement 2, sedation interruption and subglottic drainage were
not assessed. In measurement 4, subglottic drainage was not
assessed. Good, intermediate, and poor adherence were defined as
≥80%, ≥50%–80%, and <50% adherence, respectively.
Theoretical framework
The behavior change wheel (BCW) is a theoretical framework that
incorporates several existing behavior-change frameworks into a
behavioral system (COM-B) composed of 3 ‘sources of behavior’:
capability, opportunity, and motivation.32 The BCW was chosen
to guide the analysis in this study because it is an overarching
framework that considers the influence of context on individual
behavior. A further advantage of the BCW is that it links barriers
and facilitators identified within the COM-B system to proposed
interventions that may be effective in addressing deficits (Table 1).
Focus group interviews—Data collection and analysis
The 6 focus group interviews, 1 per ICU, were conducted between
May 4 and June 5, 2015. We used a purposeful criterion sampling
approach,33 and we sought to include both nurses and physicians
from each of the 6 ICUs to gather a broad range of experiences
related to VAP prevention. Beyond these criteria, participants
included convenience samples of ICU nurses and physicians
on duty who were available when the group interview took place.
They represent a subset of the observed HCP. All semi-structured
interviews were conducted by the same IPC nurse (M.T.M.). The
interview guide is shown in Table 2. Written informed consent
was obtained from all interviewees. Interviews were held in Swiss-
German, audiotaped, and transcribed verbatim. Following a
grounded theory approach, initial data analysis was conducted
inductively by 2 investigators (A.W. and M.T.M.) to summarize
interview content and to inform the ongoing data collection.34
Following data collection, the same 2 investigators (A.W. and
M.T.M.) deductively coded all identified barriers and facilitators
according to the BCW behavioral system components: capability,
opportunity, or motivation.32 Any discrepancies in coding were
resolved by a health psychologist (L.C.). Using the same approach,
participant ideas for better bundle implementation approaches were
deductively coded according to the intervention functions of the
BCW with its 9 components: education, persuasion, incentivization,
coercion, training, restriction, environmental restructuring, model-
ing, and enablement. These participant suggestions were then
compared with the intervention functions proposed by the BCW for
addressing identified barriers and facilitators (Table 1).
Results
Adherence measurements
Data regarding adherence rates are shown in Table 3. Adherence
was poor for head of bed elevation (27%; 95% confidence intervals
[CI], 23%–31%) and oral care (41%; 95% CI, 36%–45%), though it
was good for daily sedation interruption (81%; 95% CI, 74%–
85%) and subglottic suctioning (88%; 95% CI, 83%–92%). A
considerable number of patients had a contraindication for head
of bed elevation (27%; 95% CI, 23%–31%) and sedation inter-
ruption (41%; 95% CI, 36%–46%). Also, 41% (95% CI, 36%–46%)
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of patients did not have a tube with a suction port for subglottic
suctioning.
Focus group interviews
Overall, 42 nurses and 4 physicians participated in the interviews
(Table 4); of these, 17 were male (37%). One participant withdrew
consent because the interview was audiotaped. The interviews
lasted between 35 and 45 minutes. We determined that data
saturation was achieved (ie, no new barriers and facilitators were
being identified35 after the fourth focus group), but we continued
data collection based on our criterion sampling strategy until all
ICUs had been included.
Barriers and facilitators for adherence to the VAP bundle
according to the BCW sources of behavior
At the center of the BCW framework lie the ‘sources of behavior’, 6
essential components that shape behavior: physical and psycholo-
gical capability, reflective and automatic motivation, and physical
and social opportunity.32 The interviewee’s statements about bar-
riers and facilitators for adherence to the prevention measures were
coded according to these components (Table 5). A total of 104
statements were coded: 79 (76%) referred to barriers and 25 (24%)
to facilitators. The most commonly coded components were
‘physical opportunity’ with 49% of statements (n= 51: 47 barriers
and 4 facilitators), followed by ‘reflective motivation’ with 21%
(n= 22: 9 barriers and 13 facilitators), ‘automatic motivation’ with
12% (n= 12: 11 barriers and 1 facilitator), and ‘psychological cap-
ability’ with 10% (n= 10: 5 barriers and 5 facilitators) of statements,
respectively. ‘Social opportunity’ and ‘physical capability’ appeared
rarely, in 7% (n= 7) and 2% (n= 2), respectively.
Physical and psychological capability
‘Physical capability’, which is defined as the individual’s physical
capacity to engage in the activity, was brought up as a barrier
once, referring to the inability to estimate the correct angle of
head of bed elevation by eye. ‘Psychological capability,’ like self-
discipline, was mentioned as a facilitator. Lack of knowledge and
forgetfulness were brought up as barriers several times.
Reflective and automatic motivation
Most facilitators were related to the ‘reflective motivation’ BCW
component, defined as ‘evaluations and plans that energize and direct
behavior.’ Interviewees were aware of the frequency and consequences
of VAP and generally considered prevention measures useful to lower
VAP rates. Some HCPs, however, mentioned doubts about the effec-
tiveness of certain prevention measures like head of bed elevation and
noninvasive ventilation, which may have presented a barrier to
adherence. Numerous barriers belonged to the ‘automatic motivation’
component, that is, emotions and impulses that direct behavior. HCPs
were concerned about prevention measures affecting the patient’s well-
being, such as disturbance by the noise of the subglottic suctioning
device, uncomfortable body position due to head of bed elevation, and
unpleasant taste of the chlorhexidine mouth wash.
Physical and social opportunity
Most barriers were assigned to the group of ‘physical opportunity’
and, less commonly, ‘social opportunity’—factors that lie outside
the individual HCP. Three points emerged as being most important:
(1) lack of equipment (eg, tracheal tubes with suction port for
subglottic suctioning, chlorhexidine gel instead of mouth wash, beds
with appropriate angle measurement devices), (2) lack of adequate
staffing or time for patient care, and (3) competing priorities of
Table 2. Semi-Structured Interview Guide
Introducing Question Deepening Question
1. What crosses your mind when
you hear the term VAP?
How many patients do you estimate,
suffer from VAP on your ICU?
2. Do you think VAP is preventable? To what extent VAP is preventable?
3. Do you know the elements of the
VAP bundle in this hospital?
4. For which bundle elements is
adherence good or poor?
What do you perceive as facilitators
and barriers to adherence with
the bundle elements?
Note. VAP, ventilator-associated pneumonia.
Table 1. Links Between Components of the ‘COM-B’ Model of Behavior and Intervention Functionsa
Intervention functions
Source of Behavior Education Persuasion Incentivization Coercion Training Restriction Environmental Restructuring Modeling Enablement
Physical capabilityb √ √
Psychological capabilityc √ √ √
Reflective motivationd √ √ √ √
Automatic motivatione √ √ √ √ √ √
Physical opportunityf √ √ √
Social opportunityf √ √ √
aTable reproduced with permission from Michie et al.32
bPhysical capability can be achieved through physical skill development, which is the focus of training, or potentially through enabling interventions such as medication, surgery or
prostheses.
cPsychological capability can be achieved through imparting knowledge or understanding; training emotional, cognitive, and/or behavioral skills; or through enabling interventions such as
medication.
dReflective motivation can be achieved through increasing knowledge and understanding or through eliciting positive (or negative) feelings about behavioral target.
eAutomatic motivation can be achieved through associative learning that elicits positive (or negative) feelings and impulses and counterimpulses relating to the behavioral target, imitative
learning, or habit formation that directly influences automatic motivational processes (eg, via medication).
fPhysical and social opportunity can be achieved through environmental change.
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patients and prevention measure (eg, head of bed elevation not
possible due to the increased need for catecholamines or sedation
interruption increasing intracranial pressure). Only rarely did HCPs
mention the available infrastructure as a facilitator for bundle
adherence. For ‘social opportunity,’ or the cultural milieu, cham-
pions were brought up as facilitators and lack of hierarchical sup-
port was mentioned as barrier for bundle adherence.
Intervention ideas according to the BCW intervention
functions
The spontaneously mentioned ideas to improve bundle adherence
were provision or improvement of equipment, which we mapped
to the ‘environmental restructuring’ component. The introduc-
tion of a device to indicate head of bed elevation and tracheal
Table 3. Quantitative Adherence Rates to VAP Prevention Measures
Bundle Element
Measurements
(No. of observations)
% Adherence in Patients
Without Contraindications (95% CI)
% Patients With Contraindication
of All Patients (95% CI)
Head of bed elevation 1: February 2015 (n= 235) 23 (17–30) 19 (14–24)
2: August 2015 (n= 134) 16 (9–24) 24 (17–32)
3: July 2016 (n= 78) 50 (34–66) 46 (35–58)
4: July 2017 (n= 194) 32 (25–40) 18 (12–24)
Overall (n= 641) 27 (23–31) 23 (20–26)
Sedation interruption 1: February 2015 (n= 68) 81 (65–92) 46 (33–58)
2: August 2015 N/A N/A
3: July 2016 (n= 58) 63 (44–80) 48 (35–62)
4: July 2017 (n= 103) 88 (78–94) 27 (19–37)
Overall (n= 229) 81 (74–87) 38 (32–45)
Oral care 1: February 2015 (n= 126) 43 (34–52) N/A
2: August 2015 (n= 116) 38 (29–47) N/A
3: July 2016 (n= 73) 30 (20–42) N/A
4: July 2017 (n= 169) 46 (38–53) N/A
Overall (n= 484) 41 (36–45) N/A
Subglottic suctioning 1: February 2015 (n= 236) 90 (84–95) 45 (38–52)a
2: August 2015 N/A N/A
3: July 2016 (n= 140) 86 (77–92) 34 (26–43)a
4: July 2017 N/A N/A
Overall (n= 222) 88 (83–92) 41 (36–46)a
Note. CI, confidence interval; N/A, not applicable.
a“Contraindication” for subglottic suctioning: no tube with suction port.
Table 4. Focus Group Interview Participants
Type of ICU No. of Nurses No. of Physicians Total Male Participants, No. (%)
Burn ICU 4 0 4 2 (25)
Medical ICU 6 0 6 3 (50)
Thoracic and transplant surgery ICU 9 0 9 1 (11)
Neurosurgery ICU 9 1 10 4 (40)
Cardiac surgery ICU 8 2 10 4 (40)
Trauma ICU 6 1 7 3 (43)
Total 42 4 46 17 (37)
Note. ICU, intensive care unit.
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tubes with ports for subglottic suctioning were most often men-
tioned. Second, alarm systems as reminders were mentioned
several times, predominantly in the context of head of bed ele-
vation, which we mapped to the components ‘environmental
restructuring’ and ‘HCP enabling.’ Third, introduction of proto-
cols and checklist for the bundle in general and for sedation
interruption specifically were brought up, which belong to the
components ‘restriction’ and ‘HCP enabling,’ respectively. Table 6
outlines observed adherence measures, self-reported adherence
rates, and barriers, facilitators, and intervention ideas according
the BCW for every VAP bundle component.
Discussion
This mixed-method study measured adherence to 4 VAP pre-
vention measures and found poor adherence to head of bed ele-
vation and oral care and good adherence to sedation vacation and
subglottic suctioning. Corresponding to the BCW ‘sources of
behavior,’ facilitators for adherence belonged primarily to the
component ‘reflective motivation’: perceived seriousness of VAP
and self-efficacy to prevent VAP. Barriers mainly belonged to the
BCW component ‘physical capability’: lack of equipment and
staffing and side-effects of prevention measures. To improve
Table 5. Barriers and Facilitators Identified From the Focus Group Interviews Mapped According to the Behavior Change Wheel Framework
Sources of
Behavior
Components Subdivision Description Barriers: Typical Quotes From the Interviews
Facilitators: Typical Quotes From
the Interviews
Capability Physical Individual’s physical
capability to engage
in the behavior
Female nurse: “30° is very steep indeed. We often
underestimated how steep 30° is.” (inability to estimate
angle)
N.A.
Psycho-logical Individual’s
psychological
capability (eg,
comprehension,
reasoning) to
engage in the
behavior
Male physician: “We do oral care with chlorhexidine...” -
checks back with the group: “Yes, we do. Is this [an]
official [prevention measure]?” (lack of knowledge)
Male nurse: “Sometimes people forget one or the other
thing.” (forgetfulness)
Male nurse: “I think we have to …
bring the subject over and over
back into our minds to not forget
to apply the prevention
measures.” (self-discipline,
awareness)
Motivation Reflective Evaluations or plans
that energize and
direct behavior
Male physician: “This head of bed elevation... the beneficial
effect is not really proven, right?” (lack of evidence)
Female nurse: “The patients with noninvasive ventilation,
they are often struggling ... they swallow air, then burp
and then aspirate.” (perceived inefficacy of prevention
measure)
Male physician: “VAP is one of the
most common nosocomial
infections in the ICU.” (perceived
importance of VAP)
Female nurse: “I do believe we can
prevent VAP—at least 50% of VAP
are preventable, or even more!”
(perceived preventability of VAP)
Automatic Emotions and
impulses that that
energize and direct
behavior
Female nurse: “... this continuous subglottic drainage ... to
hear this noise 24h a day ... that is a nuisance for the
patients.” (perceived conflict with patient’s well-being)
Female nurse: “We do turn our patients to the side. Then,
head of bed elevation to 30° is really uncomfortable.”
(perceived conflict with patient’s well-being)
Female nurse: “Oral care with
chlorhexidine … I do that all the
time, automatically.” (habit)
Opportunity Social Cultural milieu outside
the individual that
make the behavior
possible or prompt
it
Female nurse: “Head of bed elevation and mobilization of
the patient is really important, and I find it too bad that
we don’t get support from our head nurse to do it
properly – and get enough time for that.” (hierarchical
structures, social influence)
Male nurse: “To decide about contraindications is in the
decision power of the physician team [vs the nurse
team].” (professional role and responsibilities)
Male nurse: “This one surgeon, Dr.
S., he is really strict. He wants all
his patients to have head of bed
elevation of more than 30°,
always.” (champions)
Physical Environment outside
the individual that
make the behavior
possible or prompt
it
Female nurse: “I left patients intubated on the ventilator
overnight [even though they were ready to extubate]
because I was responsible for 2 patients.” (lack of
staffing/time)
Female nurse: “… head of bed elevation of 30° or higher is
important. [But] this is often not possible, if the patient
has a high amount of catecholamines running.” (side
effects of prevention measures)
Male nurse: “I do not understand why we do not have a
tracheostomy tube with a subglottic suction system.”
(barrier: lack of devices)
Male nurse: “This oral care... when the patients are not
deeply sedated, they just swallow the chlorhexidine, and
off it goes...!” (feasibility)
Male nurse: “You know, they do not
save money for technical things
... all our patients now do have
this machine for subglottic
suctioning.” (infrastructure/
equipment)
Note. ICU, intensive care unit; VAP, ventilator-associated pneumonia.
Infection Control & Hospital Epidemiology 5
Table 6. Outline of Self-Reported Versus Measured Adherence Rates, Mapped Barriers and Facilitators, and Intervention Opportunities
Observed Overall
Adherence, % (95% CI) Barriers Facilitators Proposed Interventions
BCW Proposed
Intervention Functions
UHZ VAP prevention
bundle overall
N.A. - Physical opportunity (staffing/time)
- Social opportunity (hierarchical structures)
- Psychological capability
(comprehension and reasoning)
- Reflective motivation (relevance of
VAP, belief in preventability)
- Enablement (checklists)
- Restrictions (protocols)
- Restriction
- Environmental restructuring
- Enablement
Continuous application
of a sedation and
weaning protocol
81 (74–87) - Psychological capability (forgetfulness)
- Physical opportunity (staffing/time)
- Social opportunity (coworkers) - Enablement (checklists)
- Restrictions (protocols)
- Restriction
- Environmental restructuring
- Enablement
- Education
- Training
Head of the bed
elevation of ≥30°
27 (23–31) - Physical capability (inability to estimate
angle)
- Psychological capability (forgetfulness)
- Reflective motivation (lack of evidence)
- Automatic motivation (conflict with
patient’s well-being)
- Physical opportunity (side effects,
infrastructure/equipment)
- Social opportunity (champions) - Environmental restructuring
(eg, bed with angle indicator)
- Enablement (alarm system)
- Enablement (checklists)
- Restrictions (protocols)
- Restriction
- Environmental restructuring
- Enablement
- Education
- Training
- Persuasion
- Incentivisation
- Coercion
- Modelling
Oral decontamination
with chlorhexidine
mouth wash
41 (36–45) - Automatic motivation (conflict with
patient well-being)
- Physical opportunity (infrastructure/
equipment, feasibility)
- Automatic motivation (habit)
- Reflective motivation (belief in
prevention measure)
- Environmental restructuring (eg,
providing mouth wash in gel form)
- Restriction
- Environmental restructuring
- Enablement
- Persuasion
- Incentivization
- Coercion
- Modelling
Use of endotracheal
tubes with
continuous subglottic
secretion drainage
88 (83–92) - Physical opportunity (infrastructure/
equipment)
- Physical opportunity
(infrastructure/equipment)
- Environmental restructuring (eg,
tracheal tubes with suction port)
- Restriction
- Environmental restructuring
- Enablement
Hand hygiene according
to the WHO 5
moments concept
N.A. - Physical opportunity (staffing/time) N.A. N.A. - Restriction
- Environmental restructuring
- Enablement
Use of non-invasive
ventilation (NIV)
whenever feasible
N.A. - Reflective motivation (lack of evidence,
disbelief in prevention measure)
- Physical opportunity (competing priorities,
staffing/time)
N.A. N.A. - Restriction
- Environmental restructuring
- Enablement
Periodic changes of
ventilator tubing and
filters
N.A. N.A. N.A. N.A.
Use of closed suction
systems
N.A. - Physical opportunity (infrastructure
equipment)
- Physical opportunity
(infrastructure equipment)
N.A. - Restriction
- Environmental restructuring
- Enablement
Daily evaluation of
stress ulcer
prophylaxis to limit
its use
N.A. N.A. N.A. N.A.
Note. BCW, behavior change wheel; N.A., not applicable. This table summarizes the adherence rates assessed by observation and reported barriers, facilitators, and proposed interventions mapped according to intervention functions of the BCW
framework.32
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adherence, both HCPs and the BCW framework suggested 2 main
interventions, ‘restructuring the environment’ and ‘enablement
of HCP.’
VAP prevention measures were shown to be poorly executed by
other investigators: Adherence to head of bed elevation or to daily
sedation interruption, for example, was reported to be 25%–
35%,36–39 and 29%–56%,40,41 respectively. In our study, we found
good adherence for sedation vacation, but adherence rates may have
been overly optimistic because a considerable percentage of patients
were judged to have contraindications for this prevention measure
and because some of these contraindications might have been
relative. On the other hand, the interviews revealed that adherence
to oral care with chlorhexidine was low due to poor documentation
rather than missing execution. For the other 3 measured bundle
elements, self-assessment of interviewees corresponded largely with
the measured adherence. For another 3 of the 5 bundle elements not
measured (ie, hand hygiene, NIV, and daily evaluation of stress
ulcer prophylaxis), adherence was considered improvable by the
interview participants (data not shown).
Semi-structured interviews identified 2 main facilitators for
bundle adherence, both belonging to the BCW component ‘reflec-
tive motivation.’ First, VAP was perceived as a serious and common
problem among ICU patients. Many interviewees, especially nurses,
estimated VAP incidence at 50% of ventilated patients, corre-
sponding to VAP rates of around 40% of studies applying the
Clinical Pulmonary Infection Score (CPIS) criteria.3,42 Second,
HCPs perceived prevention measures to lower VAP rates by as
much as 30%–80%, corresponding to 52% and 55% in scientific
reports.23,24 These noticeably accurate estimations might represent
important prerequisites for protocol adherence.
Many of the barriers belonged to the BCW component ‘phy-
sical capability.’ HCPs were not satisfied with the quality of the
equipment or regretted lack of specific devices (eg, tracheal tubes
with a suction port) and staffing levels. From the existing litera-
ture, the unavailability of resources is a well-known barrier.43,44
On the other hand, many HCPs raised concern over side effects of
prevention measures (eg, head of bed elevation leading to
increased need for catecholamines, belonging to component
‘physical capability’). Some HCPs were subjectively concerned
about the patient’s well-being (eg, perception that head of bed
elevation is uncomfortable for the patient, belonging to the
component ‘automatic motivation’). These findings have not been
described elsewhere in the literature.
The BCW framework offers specific interventions to change
behavior by linking sources of behavior to intervention functions
(Table 1).32 Notably, the proposals of interviewees matched those
found in the BCW (Table 5). To approach the 2 main barrier
components ‘physical opportunity’ and ‘automatic motivation,’ the
BCW proposes ‘environmental restructuring’ and ‘enablement’; the
latter is considered to ‘going beyond education and training and
beyond environmental restructuring.’32 This is consistent with our
finding that HCPs asked for better equipment, checklists, and alerts.
Of special interest, both the interviewees and the BCW proposed
almost exclusively technical solutions. The benefit of technical
solutions is supported by Cafazzo’s ‘hierarchy of intervention
effectiveness.’45 This management theory promotes system-focused
or technological interventions over interventions that require con-
scious effort and change of behavior because the latter are notor-
iously more difficult to implement and sustain.45,46 Concretely, our
study revealed that the HCPs in our ICUs need (and request) a
restructured work environment that provides forcing functions and
automated or computerized processes.
Our study has several limitations. While we included all partici-
pating ICUs, the individual participants were recruited from a con-
venience sample of HCPs with an oversampling of nurses, and we
cannot fully exclude the possibility that some opinions may have been
missed. The quantitative measures were conducted in a pragmatic
quality improvement context and included measurement points with
small numbers of observations. Observations were not covered and
adherence might have been overestimated because individuals modify
their behavior when being observed (ie, the Hawthorne effect).
Because this was a single-center study, the findings might not be
generalizable to other settings. However, it covered 6 self-contained
ICUs of different specializations and cultures.
In conclusion, adherence to 2 of 4 assessed prevention mea-
sures of our VAP bundle was assessed to be improvable, and
barriers for adherence predominantly belonged to external rea-
sons such as lack of adequate equipment or staffing or side effects
of prevention measures. Mapping the inductively identified
themes against the BCW framework pinpointed the need to
‘restructure the environment’ and to ‘enable HCPs.’ These find-
ings were underpinned by the proposals of the interviewees, who
also predominantly advocated for technical solutions to improve
their adherence to VAP prevention measures. The BCW-
informed mixed-method approach is an effective means for
guiding infection prevention efforts. Further research is needed to
assess the impact of these interventions on adherence rates.
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